z.antonsen
Submits third-party assay reports on material purchased directly. Based in Pune.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.18%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042722 | Tirzepatide | ERP | ERP-2512-T9616 | Medutest | 2026-Q2 | 99.18 | 2.07 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019262 | GHRP-6 | AMB | AMB-2508-T5301 | Medutest | 2025-Q3 | 99.16 | 5.93 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020461 | Tirzepatide | KP | KP-2504-V5402 | Janoshik | 2025-Q3 | 98.26 | 4.63 | 99.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020114 | Semaglutide | ERP | ERP-2508-S8293 | Janoshik | 2025-Q3 | 99.49 | 3.39 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018458 | TB-500 | WWB | WWB-2504-F3053 | Janoshik | 2025-Q3 | 99.31 | 5.56 | 96.5 | Buyer-sourced | 0 | PASS |
| AX-2025-020699 | CJC-1295 (no DAC) | SGN | SGN-2412-L9210 | Medutest | 2025-Q2 | 99.31 | 5.34 | 107.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019985 | Tirzepatide | HJ | HJ-2505-H6642 | Janoshik | 2025-Q2 | 98.53 | 5.43 | — | Buyer-sourced | 0 | PASS |